Protect consumers' right to sue drugmaker
Legal action is a shield against lax regulators. Read more...
Many Unfavorable Drug Studies Aren’t Published
Nearly a third of antidepressant drug studies are never published in the medical literature, and nearly all of those happen to show that the drug being tests failed to work. Read more...
Only Drugs That are Safe Should be put on the Market
Drug developers are just beginning to come to grips with recent FDA oversight reforms and how they will affect drug safety. But, it appears that industry and consumer advocates are not together on how well the overhaul will be able to prevent future drug safety scandals. Read more...
Updates to the Biotech/Specialty Injectable Drug List – Effective July 1st
Updates to the Biotech/Specialty Injectables List for members enrolled in Flex Copay, Flex Deductible, and PPO HSA-Qualified High Deductible Health Plans went into effect July 1, 2007.Read more...
Diabetes Drugs to Get Stronger Heart-Failure Warning (Update4)
GlaxoSmithKline Plc's Avandia and Takeda Pharmaceutical Co.'s Actos, the world's best-selling diabetes pills, will carry U.S. regulators' strictest warning on the risk of heart failure. Read more...
"I would argue that the FDA ... is incapable of protecting America against another Vioxx."
-- David Graham, FDA scientist
FORSAMAX WILL MOST LIKELY BE MERCK'S NEXT BIG PROBLEM
Fosamax, which is another Merck drug. Lawsuits are being filed nationwide by people who have suffered osteonecrosis of the jaw as a s result of taking this drug. As you know, millions of women have taken Fosamax as a preventions for osteoporosis. The drug is an even larger seller than Vioxx, with 2005 sales totaling $3.5 billion. There is no know cure for the disease, and it is said to be extremely painful. The tremendous number of people on the drug and the devastating nature of the injuries make this a potentially catastrophic and widespread problem. Jerry Taylor and Chad Cook, who practice in the Mass Torts Section of our firm, are presently investigating numerous Fosamax cases on behalf of individuals across the country. We expect to file a significant number of theses cases in the next few weeks.
Source: The Jere Beasley Report (July 2006) - Beasley Allen, Crow, Methvin, Portis & Miles, P.C. Attorneys at Law |
